发布于: 雪球转发:0回复:8喜欢:0
$Cel-Sci Corporation  ($0.001 Par Value)(CVM)$ @Just-a-Novice 因为你研究小药股经验比较丰富,想请教您一个问题:像CVM这家公司这样折价30%发行可转换票据(现价$2.4,发行票面价值$1.69)给定向投资者(包括CEO在内也购买了25万美金票面价值)的行为,在小药股里面常见吗?感觉小股东被坑得一愣一愣的,不知道我理解的对不对?
链接:网页链接

In June 22, 2017 we sold convertible notes in the principal amount of $1,510,000 to six private investors. Geert Kersten, the Company’s Chief Executive Officer, participated in the offering and purchased notes in the principal amount of $250,000.

The notes bear interest at 4% per year and are due and payable on December 22, 2017. At the option of the note holders, the notes can be converted into shares of our common stock at a conversion rate of $1.69.

The purchasers of the convertible notes also received warrants which entitle the purchasers to acquire up to 893,491 shares of our common stock. The warrants are exercisable at a price of $1.86 per share and expire on June 22, 2022.

全部讨论

2017-07-28 15:51

顺便说,如果是重要的phase 3即将readabout的话,投资人的风险会比较大。因为phase 3结果实际上连公司CEO都不会提前知道。。。

2017-07-28 15:42

折价30%太寻常了,融资啊~ 不过CVM的这个,这么小的金额,更像是管理层给自己和affiliates发福利。

话说,略微扫了一眼CVM的近期filing,觉得可能很快要有一个向上的突破。不过还需要研究一下基本面才能确认。

2017-07-24 23:04

今天又出了份公告 价格谈的很合理

2017-07-23 00:36

我2.4跑了,感觉phase3没出来,公司先被玩坏了